Patents by Inventor Kathryn Woodburn

Kathryn Woodburn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial peptides and methods of using the same
    Patent number: 11266712
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: March 8, 2022
    Assignee: Riptide Bioscience, Inc.
    Inventors: Jesse M. Jaynes, L. Edward Clemens, Henry Wilfred Lopez, George R. Martin, Kathryn Woodburn
  • Antimicrobial Peptides and Methods of Using the Same
    Publication number: 20200230200
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 23, 2020
    Inventors: Jesse M. Jaynes, L. Edward Clemens, Henry Wilfred Lopez, George R. Martin, Kathryn Woodburn
  • Antimicrobial peptides and methods of using the same
    Patent number: 10548944
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: February 4, 2020
    Assignee: Riptide Bioscience, Inc.
    Inventors: Jesse Jaynes, L. Edward Clemens, Henry Willfred Lopez, George R. Martin, Kathryn Woodburn
  • ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
    Publication number: 20190071470
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Application
    Filed: June 5, 2018
    Publication date: March 7, 2019
    Inventors: Jesse Jaynes, L. Edward Clemens, Henry W. Lopez, George R. Martin, Kathryn Woodburn
  • Antimicrobial peptides and methods of use thereof
    Patent number: 10017542
    Abstract: Aspects of the present invention relate to peptides having antimicrobial activity. In certain aspects, the invention relates to peptides having potent antimicrobial activity, broad-spectrum antimicrobial activity, and/or the ability to kill otherwise antibiotic-resistant microbes, or microbes protected by biofilms.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: July 10, 2018
    Assignee: Riptide Bioscience, Inc.
    Inventors: Jesse Jaynes, L. Edward Clemens, Henry W. Lopez, George R. Martin, Kathryn Woodburn
  • Erythropoietin receptor peptide formulations and uses
    Patent number: 7550433
    Abstract: The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: June 23, 2009
    Assignee: Affymax, Inc.
    Inventors: Anne-Marie Duliege, Richard Stead, Kerstin Leuther, Kathryn Woodburn, Robert Barnett Naso
  • ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES
    Publication number: 20080081783
    Abstract: The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided.
    Type: Application
    Filed: July 13, 2007
    Publication date: April 3, 2008
    Applicant: AFFYMAX, INC.
    Inventors: Anne-Marie Duliege, Richard Stead, Kerstin Leuther, Kathryn Woodburn, Robert Naso
  • Erythropoietin receptor peptide formulations and uses
    Publication number: 20070104704
    Abstract: The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided.
    Type: Application
    Filed: June 2, 2006
    Publication date: May 10, 2007
    Applicant: Affymax, Inc.
    Inventors: Anne-Marie Duliege, Richard Stead, Kerstin Leuther, Kathryn Woodburn, Robert Naso